The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2025

Filed:

May. 22, 2020
Applicant:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Inventors:

Jan Jensen, Cleveland, OH (US);

Michael A. Bukys, Cleveland, OH (US);

Assignee:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01); C07K 14/51 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0678 (2013.01); C07K 14/51 (2013.01); A61K 38/00 (2013.01); C12N 2501/155 (2013.01); C12N 2501/385 (2013.01); C12N 2506/02 (2013.01); C12N 2506/45 (2013.01);
Abstract

Provided herein are compositions, systems, kits, and methods for generating dorsal foregut endoderm (DFE) cells by contacting pluripotent stem cells with a retinoic acid signaling pathway agonist and a bone morphogenetic (BMP) pathway inhibitor without exposing the stem cells to a transforming growth factor beta (TGFβ) pathway agonist. In certain embodiments, the DFE cells are contacted with a retinoic acid signaling pathway agonist and a FGFR pathway inhibitor to generate pancreatic endoderm (PE) cells (e.g., with dorsal identity). In other embodiments, the PE cells are contacted with an ALK5 inhibitor and a Notch inhibitor to generate endocrine cells (e.g., insulin expressing endocrine cells). In certain embodiments, compositions, systems, kits, and methods are provided for generating anterior domain endoderm (ADE) cells.


Find Patent Forward Citations

Loading…